SSR 240600

Drug Profile

SSR 240600

Alternative Names: SSR240600; SSR240600C

Latest Information Update: 13 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sanofi-aventis
  • Class Antidepressants; Antispasmodics
  • Mechanism of Action Neurokinin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Major depressive disorder; Overactive bladder; Urinary incontinence

Most Recent Events

  • 31 Dec 2008 Discontinued - Phase-II for Depression in France (unspecified route)
  • 31 Dec 2008 Discontinued - Phase-II for Overactive bladder in Canada (PO)
  • 31 Dec 2008 Discontinued - Phase-II for Overactive bladder in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top